Causal relationship between circulating immune cells and the risk of type 2 diabetes: a Mendelian randomization study
Open Access
- 25 May 2023
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Endocrinology
- Vol. 14, 1210415
Abstract
Objectives: Though type 2 diabetes (T2D) has been known as a metabolic disease caused by multiple factors, the etiology remains insufficiently understood. Here, we aimed to figure out whether circulating immune cell profiles causally impact T2D liability.Methods: We applied one genome-wide association study (GWAS) summary statistics of blood traits in 563,085 participants from the Blood Cell Consortium and another GWAS of flow cytometric profile of lymphocyte subsets comprising 3,757 Sardinians to identify genetically predicted blood immune cells. We also obtained GWAS summary statistics in 898,130 individuals from the DIAGRAM Consortium to evaluate genetically predicted T2D. We primarily used inverse variance weighted (IVW) and weighted median methods to perform Mendelian randomization analyses and sensitivity analyses to evaluate heterogeneity and pleiotropy.Results: For circulating blood leukocyte and its subpopulations, the increase of genetically predicted circulating monocyte count was causally correlated with a higher risk of T2D [odds ratio (OR) = 1.06, 95% confidence interval (CI) = 1.02–1.10, p = 0.0048]. For lymphocyte subsets, CD8+ T cell and CD4+ CD8dim T cell count were identified with causal effect on T2D susceptibility (CD8+ T cell: OR = 1.09, 95% CI = 1.03–1.17, p = 0.0053; CD4+ CD8dim T cell: OR = 1.04, 95% CI = 1.01–1.08, p = 0.0070). No pleiotropy was determined.Conclusions: These findings demonstrated that higher circulating monocyte and T-lymphocyte subpopulation predicted increased T2D susceptibility, which confirmed the immunity predisposition for T2D. Our results may have the potential to provide new therapeutic targets for the diagnosis and treatment of T2D.Keywords
Funding Information
- Natural Science Foundation of Zhejiang Province (LQ22H250001)
- National Natural Science Foundation of China (82201712, 82022026, 92249304, 92049304, 82030039, 82230047)
- National Key Research and Development Program of China (2021YFA1102800)
- Science Fund for Distinguished Young Scholars of Guangdong Province (2019B151502008)
This publication has 36 references indexed in Scilit:
- T-Cell Profile in Adipose Tissue Is Associated With Insulin Resistance and Systemic Inflammation in HumansArteriosclerosis, Thrombosis, and Vascular Biology, 2014
- Leukocyte Profiles Differ Between Type 1 and Type 2 Diabetes and Are Associated With Metabolic Phenotypes: Results From the German Diabetes Study (GDS)Diabetes Care, 2014
- Mendelian randomization: genetic anchors for causal inference in epidemiological studiesHuman Molecular Genetics, 2014
- Clinical and Genetic Determinants of Progression of Type 2 Diabetes: A DIRECT StudyDiabetes Care, 2014
- An unbalanced monocyte polarisation in peripheral blood and bone marrow of patients with type 2 diabetes has an impact on microangiopathyDiabetologia, 2013
- White Blood Cells Count and Incidence of Type 2 Diabetes in Young MenDiabetes Care, 2013
- Elevated Proinflammatory Cytokine Production by a Skewed T Cell Compartment Requires Monocytes and Promotes Inflammation in Type 2 DiabetesThe Journal of Immunology, 2011
- Type 2 diabetes as an inflammatory diseaseNature Reviews Immunology, 2011
- Defective Suppressor Function in CD4+CD25+ T-Cells From Patients With Type 1 DiabetesDiabetes, 2005
- ‘Mendelian randomization’: can genetic epidemiology contribute to understanding environmental determinants of disease?*International Journal of Epidemiology, 2003